📰 Daptorum Group News
Page 4 - Daptorum Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daptorum Group. Real-time updates on events, politics, business and more.
March 27, 2023
Regulatory News: Aptorum Group Limited , today announced that it entered into a non-binding Letter of Intent and Term Sheet for the acquisition of 100% of URF Holding Group Limited and its... | March 27, 2023
March 27, 2023
Aptorum Group Ltd. (APM) announced Monday that it entered into a non-binding Letter of Intent and Term Sheet for the acquisition of 100% of URF Holding Group Ltd.
March 17, 2023
ORLANDO, FL / ACCESSWIRE / March 17, 2023 / RedChip Companies will air new interviews with Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) and ASP Isotopes Inc. (Nasdaq:ASPI) on The RedChip Money
March 3, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of an end of Phase 1
March 3, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, announces the completion of the Pre-IND discussions
March 2, 2023
02.03.2023 - Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling unmet medical needs, announces the exciting ... Seite 1
March 2, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to tackling
February 10, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology
February 6, 2023
Regulatory News: Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today... | February 6, 2023
January 20, 2023
Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (the "Company") a clinical stage biopharmaceutical company dedicated to tackling unmet medical needs in oncology, autoimmune